Search Results

Pediatric patients who have severe forms of lung disease associated with respiratory failure often need transplantable lung tissues and this study proves generating transplantable lungs from stem cells using large animals as bioreactors is possible.

In a move that strengthens the medical leadership of Phoenix Children’s, the health system today announced a new chief medical officer (CMO) as well as the expansion of the CMO office to include two associate CMOs.

In his new role, Dr. Patel leads four of Phoenix Children’s eight clinical centers. He also oversees hospitalist medicine, mental and behavioral health, and Phoenix Children’s Pediatrics practices. Beyond his clinical responsibilities, Dr. Patel is now part of the health system’s Executive Physician Leadership team and the Phoenix Children’s Medical Group Governance Council.

On May 1, Phoenix Children’s will unveil a 407-foot commissioned mural that has transformed a heavily trafficked corridor into a captivating and exciting journey for children and their families. Nearly two years in the making, the art installation, called “Wonder And Wander” brings vibrant colors and imaginative designs to a major hospital hallway through which 70,000 children are transported each year.

Dr. Hauptman, who assumes his post in June, is a highly regarded pediatric neurosurgeon, researcher and professor. A practicing surgeon for more than 10 years, Dr. Hauptman offers unique expertise in the surgical management of pediatric epilepsy, removal of tumors in eloquent brain regions and treatment of congenital brain and spine anomalies in infants and young children.

Research conducted at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine — Phoenix shows normalizing cancer tumor vessels and alleviating low oxygen levels in the tumor microenvironment can improve the effectiveness of chemotherapy treatment in lung cancer, according to a paper published in EMBO Molecular Medicine.